The seed round was led by Norrsken VC to help expand the company software for tracking renewable energy sources.
"One of the most effective things anyone can do to reduce their carbon footprint is to purchase energy from carbon-free sources. We’re helping energy companies create more transparent offers for their customers to make switching to clean energy more accessible and more impactful. Consumers deserve to know whether their electricity comes a source that is either destroying our planet or is part of our future."
The pre seed round was led by Seedcamp with backing from Evolvient Capital and angel investors.
"After speaking with industry leaders, they made it clear that if friction from self-assessment could be removed and a more cost-effective model be put in place, then there was a great opportunity for mass adoption."
Creandum led the Series A round with participation from Peter Thiel, firstminute, Seedcamp, Hambro Perks and Amino Collective.
"Clinical trials are the biggest bottleneck to improving human health. We deliver clinical trials three times faster than the industry standard, working with biotech pioneers to get new treatments to patients more quickly."
The London carbon data provider secured capital from a mix of new and existing investors to grow its New York presence.
"There is a serious lack of data to demonstrate progress against net zero targets and to prove that carbon emissions are actually being reduced or removed from the atmosphere. This uncertainty has created inaction–Sylvera is changing that,"
